Acute heart failure treatment

James D Kirk; Gerasimos Filippatos; Mihai Gheorghiade; Peter S. Pang; Phillip Levy; Ezra A Amsterdam; W. Frank Peacock; Gregg C. Fonarow

doi:10.1097/HPC.0b013e318177df37

Acute heart failure treatment

James D Kirk, Gerasimos Filippatos, Mihai Gheorghiade, Peter S. Pang, Phillip Levy, Ezra A Amsterdam, W. Frank Peacock, Gregg C. Fonarow

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

Emerging concepts in the short term management of acute heart failure have fostered changes in therapeutic targets and the expectations of emergency department and in-hospital treatment options. Investigators and clinicians are now reconsidering how intravenous diuretics, vasodilators, and inotropes commonly used to alleviate congestion and restore hemodynamic stability should be administered; which acute heart failure patients should receive them; and the long-term morbidity and mortality implications of these decisions. This section evaluates these various therapeutic options for patients appropriate for short stay unit management.

Original language	English (US)
Pages (from-to)	103-110
Number of pages	8
Journal	Critical Pathways in Cardiology
Volume	7
Issue number	2
DOIs	https://doi.org/10.1097/HPC.0b013e318177df37
State	Published - Jun 2008
Externally published	Yes

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1097/HPC.0b013e318177df37

Fingerprint Dive into the research topics of 'Acute heart failure treatment'. Together they form a unique fingerprint.

Cite this

@article{581f82a516a04d0aa6d2fa92e7040e4a,

title = "Acute heart failure treatment",

abstract = "Emerging concepts in the short term management of acute heart failure have fostered changes in therapeutic targets and the expectations of emergency department and in-hospital treatment options. Investigators and clinicians are now reconsidering how intravenous diuretics, vasodilators, and inotropes commonly used to alleviate congestion and restore hemodynamic stability should be administered; which acute heart failure patients should receive them; and the long-term morbidity and mortality implications of these decisions. This section evaluates these various therapeutic options for patients appropriate for short stay unit management.",

author = "Kirk, {James D} and Gerasimos Filippatos and Mihai Gheorghiade and Pang, {Peter S.} and Phillip Levy and Amsterdam, {Ezra A} and Peacock, {W. Frank} and Fonarow, {Gregg C.}",

year = "2008",

month = jun,

doi = "10.1097/HPC.0b013e318177df37",

language = "English (US)",

volume = "7",

pages = "103--110",

journal = "Critical Pathways in Cardiology",

issn = "1535-282X",

publisher = "Lippincott Williams and Wilkins",

number = "2",

}

TY - JOUR

T1 - Acute heart failure treatment

AU - Kirk, James D

AU - Filippatos, Gerasimos

AU - Gheorghiade, Mihai

AU - Pang, Peter S.

AU - Levy, Phillip

AU - Amsterdam, Ezra A

AU - Peacock, W. Frank

AU - Fonarow, Gregg C.

PY - 2008/6

Y1 - 2008/6

N2 - Emerging concepts in the short term management of acute heart failure have fostered changes in therapeutic targets and the expectations of emergency department and in-hospital treatment options. Investigators and clinicians are now reconsidering how intravenous diuretics, vasodilators, and inotropes commonly used to alleviate congestion and restore hemodynamic stability should be administered; which acute heart failure patients should receive them; and the long-term morbidity and mortality implications of these decisions. This section evaluates these various therapeutic options for patients appropriate for short stay unit management.

AB - Emerging concepts in the short term management of acute heart failure have fostered changes in therapeutic targets and the expectations of emergency department and in-hospital treatment options. Investigators and clinicians are now reconsidering how intravenous diuretics, vasodilators, and inotropes commonly used to alleviate congestion and restore hemodynamic stability should be administered; which acute heart failure patients should receive them; and the long-term morbidity and mortality implications of these decisions. This section evaluates these various therapeutic options for patients appropriate for short stay unit management.

UR - http://www.scopus.com/inward/record.url?scp=67650118200&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650118200&partnerID=8YFLogxK

U2 - 10.1097/HPC.0b013e318177df37

DO - 10.1097/HPC.0b013e318177df37

M3 - Article

AN - SCOPUS:67650118200

VL - 7

SP - 103

EP - 110

JO - Critical Pathways in Cardiology

JF - Critical Pathways in Cardiology

SN - 1535-282X

IS - 2

ER -

Acute heart failure treatment

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this